chemotherapy/infarction

Lyen an sove nan clipboard la

Chwazi kalite sòt

Paj 1 soti nan 92 rezilta yo

Evaluation of New Biomarker-based Approaches for Improving the Diagnosis of Childhood Tuberculous Meningitis

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

IMPORTANCE AND RELEVANCE TO EDCTP2 Despite considerable ongoing efforts in the development of tools to combat tuberculosis (TB), the disease was responsible for approximately 1.6 million deaths, with 10 million people developing the disease worldwide in 2017 (1). An estimated one million children

Feasibility of Switching Fluoropyrimidine Due to Cardiotoxicity Study

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Fluoropyrimidine chemotherapy agents, such as 5-fluorouracil and capecitabine, are occasionally associated with cardiotoxicity that may manifest as chest pain, ECG alterations, cardiac arrhythmia, and rarely myocardial infarction and sudden death. Clinical fluoropyrimidine cardiotoxicity is

Mechanism and Outcome of Acute Ischemic Stroke in Cancer Patients

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

- Retrospective study was conducted on patients diagnosed with cancer receiving chemotherapy or radiotherapy to evaluate the relation between cancer or cancer therapies and ischemic stroke development. - Patients had been recruited from the oncology center, nuclear medicine department and neurology

Study of Anlotinib Plus Chemoradiotherapy in Patients With Locally Advanced NSCLC

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Lung cancer is the most common cancer, accounting for 20% of cancer-related deaths worldwide. In 2015, an estimated 610,200 patients (22 per cent of cancer-related deaths) died of lung cancer. Non-small cell lung cancer ((NSCLC)) accounts for 80% to 85% of lung cancer. Most patients are locally

A Study to Evaluate Camrelizumab in Combination With Docetaxel +S-1 as Adjuvant Treatment Therapy in Stage III Gastric Cancer

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

1. Test population: Patients with stage III gastric cancer confirmed by postoperative pathology 2. Sample size calculation: single arm design was used in this study, and the main outcome was progression free survival. In this study, PD-L1 + CPS ≥ 10% / MSI-H + / EB +, the sample size was estimated

Cardiovascular Events in GnRH Agonist vs. Antagonist

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Study design: Randomized phase-2, open label superiority study of the use of ADT combined with second line hormonal or chemotherapy in men with advanced prostate cancer and pre-existing cardiovascular risks. Study population: Subjects with pre-existing cardiovascular risk with locally advanced or

Long Term Complications in Head and Neck Cancer Patients

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Observational Trial of Cardiotoxicity in Patients Undergoing Chemotherapy.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The Role of Guideline-adherent Perioperative Antibiotic Administration and the Risk of Surgical Site Infections After Non-cardiac Surgery.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Introduction: Prevention of surgical site infection (SSI) continues to be a major challenge for the health care system since it incurs a substantial toll on public health and significantly inflates health care costs. SSIs are now the leading cause of health care related infections, complicating

Hypertension Management in Cancer Patients

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

This is a 12-week prospective study with two phases. In Phase 1 (Weeks 1-4), participants will self-monitor their blood pressure using the Qardio bluetooth device. In Phase 2 (Weeks 5-12), the investigators will implement the auto-messaging system triggered by a weekly average systolic blood

Vascular Functions in Myeloma Patients During Anti-tumor Therapy

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Treatment options for multiple myeloma have increased significantly over the last years with the approval of immunomodulatory drugs (IMiDs) and proteasome inhibitors (PIs). These therapies have markedly improved overall survival for these patients to a median of 5-7 years, many continue to live for

Multi-center, Open-label, Phase 1b Clinical Trial to Evaluate the Safety, Tolerability, and Exploratory Efficacy of TEW-7197 in Combination With FOLFOX in Patients With Metastatic Pancreatic Ductal Adenocarcinoma Who Have Failed First-Line Gemcitabine and Nab-Paclitaxel

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

CPET and Outcome After Oesophagogastric Cancer Surgery

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Study overview and background We hypothesise that reduced physical fitness (measured objectively using Cardiopulmonary Exercise Testing (CPET)) will result in worse post-operative surgical outcome (reduced 1-year overall survival, and increased in-hospital morbidity measured by

Cancer Anesthesia and Frailty

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

A prospective data collection of pre-intra and postoperative variables will be collected in a cohort of subjects undergoing cancer relate surgery at the Fondazione IRCCS Istituto Nazionale dei Tumori, Milano. BEFORE SURGERY Subjects will be stratified before surgery according to the following three

Study in the Treatment of HCC With a Radiopaque (RO) Bead (LC Bead LUMI™) Loaded With Doxorubicin

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The usual treatment for HCC is to perform a procedure to the tumor known as Transarterial Chemo-Embolization (TACE). TACE has been approved and used worldwide for over 10 years. Transarterial means that the treatment is delivered using a catheter inserted into the hepatic artery. Embolization is a

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye